Discovery on Target Virtual, September 16-18 2020

Adult Stem Cell Organoids: a Patient in the Lab

Key to the development of the HUB Organoid Technology was the discovery of adult stem cells by Hans Clevers. Provided with the appropriate growth factors, the adult stem cells form a polarized epithelium in which stem cells and their differentiated offspring maintain their natural hierarchy and function. In addition, the organoids are genetically stable during prolonged culture. Subsequently, we developed organoid technology for most other epithelia. High-establishment efficiency means that we can use the Organoid Technology to generate disease models from virtually all patients.

Presenter: Dr. Robert Vries (CEO HUB)

Date: September 16, 2020

Time: 9:30 AM EDT

link: Discovery on Target Virtual

October 21, 2020 Webinar: Drug Discovery Powered by HUB Organo... Drug Discovery Powered by HUB Organoids and OcellO 3D Image Analysis Summary: More clinically relevant models are urgent... read more
September 04, 2020 HUB and BGI-Qingdao sign a Memorandum of Unde... Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced today that they ... read more
May 27, 2020 Studying the development of ovarian cancer wi... read more